Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk

Hypertension

Volumn 69, Issue 2, 2017, Pages 323-331

  Zaldivia, Maria T K ^a,c   Rivera, Jennifer ^a   Hering, Dagmara ^b,d   Marusic, Petra ^b,d   Sata, Yusuke ^b   Lim, Bock ^a   Eikelis, Nina ^b   Lee, Rebecca ^b   Lambert, Gavin W ^b   Esler, Murray D ^b   Htun, Nay M ^a,c   Duval, Jacqueline ^b   Hammond, Louise ^b   Eisenhardt, Steffen U ^a,e   Flierl, Ulrike ^a   Schlaich, Markus P ^a,b,c,d   Peter, Karlheinz ^a,c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Neurovascular Hypertension and Kidney Disease   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

hypertension; inflammation; monocyte activation; renal denervation; sympathetic nervous system

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; KIDNEY DENERVATION; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK REDUCTION; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; ADOLESCENT; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CATHETER ABLATION; FLOW CYTOMETRY; FOLLOW UP; INNERVATION; KIDNEY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SYMPATHECTOMY; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CATHETER ABLATION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; MONOCYTES; PLATELET AGGREGATION; PROSPECTIVE STUDIES; SYMPATHECTOMY; TIME FACTORS; YOUNG ADULT;

EID: 85004154137     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08373     Document Type: Article

References (38)

1. Esler M, Lambert E, Schlaich M, Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol (1985) 2010 109 1996 1998. discussion 2016. doi: 10.1152/japplphysiol.00182.2010.
2. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP, Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013 61 457 464. doi: 10.1161/HYPERTENSIONAHA.111.00194.
3. Henegar JR, Zhang Y, De Rama R, Hata C, Hall ME, Hall JE, Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. Am J Hypertens 2014 27 1285 1292. doi: 10.1093/ajh/hpu048.
4. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M, Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 2009 373 1275 1281. doi: 10.1016/S0140-6736(09)60566-3.
5. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD, Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014 383 622 629. doi: 10.1016/S0140-6736(13)62192-3.
6. Dörffel Y, Lätsch C, Stuhlmüller B, Schreiber S, Scholze S, Burmester GR, Scholze J, Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999 34 113 117
7. Hilgers KF, Hartner A, Porst M, Mai M, Wittmann M, Hugo C, Ganten D, Geiger H, Veelken R, Mann JF, Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 2000 58 2408 2419. doi: 10.1046/j.1523-1755.2000.00424.x.
8. Wenzel P, Knorr M, Kossmann S, Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 2011 124 1370 1381. doi: 10.1161/CIRCULATIONAHA.111.034470.
9. Heidt T, Sager HB, Courties G, Chronic variable stress activates hematopoietic stem cells. Nat Med 2014 20 754 758. doi: 10.1038/nm.3589.
10. Motulsky HJ, Cunningham EM, DeBlasi A, Insel PA, Desensitization and redistribution of beta-Adrenergic receptors on human mononuclear leukocytes. Am J Physiol 1986 250 5 pt 1 E583 E590
11. Eisenhardt SU, Schwarz M, Schallner N, Soosairajah J, Bassler N, Huang D, Bode C, Peter K, Generation of activation-specific human anti-AlphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 2007 109 3521 3528. doi: 10.1182/blood-2006-03-007179.
12. Eisenhardt SU, Schwarz M, Bassler N, Peter K, Subtractive single-chain antibody (scFv) phage-display: Tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat Protoc 2007 2 3063 3073. doi: 10.1038/nprot.2007.455.
13. Ziegler-Heitbrock L, Ancuta P, Crowe S, Nomenclature of monocytes and dendritic cells in blood. Blood 2010 116 e74 e80. doi: 10.1182/blood-2010-02-258558.
14. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL 3rd, Goldberg RJ, Michelson AD, Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001 38 1002 1006
15. Powell CC, Rohrer MJ, Barnard MR, Peyton BD, Furman MI, Michelson AD, Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg 1999 30 844 851
16. Singh MV, Davidson DC, Jackson JW, Singh VB, Silva J, Ramirez SH, Maggirwar SB, Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-Associated neuroinflammation. J Immunol 2014 192 4674 4684. doi: 10.4049/jimmunol.1302318.
17. Xiao L, Kirabo A, Wu J, Saleh MA, Zhu L, Wang F, Takahashi T, Loperena R, Foss JD, Mernaugh RL, Chen W, Roberts J 2nd, Osborn JW, Itani HA, Harrison DG, Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension. Circ Res 2015 117 547 557. doi: 10.1161/CIRCRESAHA.115.306010.
18. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ, The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007 204 3037 3047. doi: 10.1084/jem.20070885.
19. Tsujioka H, Imanishi T, Ikejima H, Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009 54 130 138. doi: 10.1016/j.jacc.2009.04.021.
20. Berg KE, Ljungcrantz I, Andersson L, Bryngelsson C, Hedblad B, Fredrikson GN, Nilsson J, Björkbacka H, Elevated CD14++CD16-monocytes predict cardiovascular events. Circ Cardiovasc Genet 2012 5 122 131. doi: 10.1161/CIRCGENETICS.111.960385.
21. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998 394 894 897. doi: 10.1038/29788.
22. Eikelis N, Hering D, Marusic P, Sari C, Walton A, Phillips S, Lambert E, Duval J, Krum H, Lambert G, Esler M, Schlaich M, The effect of renal denervation on endothelial function and inflammatory markers in patients with resistant hypertension. Int J Cardiol 2015 188 96 98. doi: 10.1016/j.ijcard.2015.04.041.
23. Gkaliagkousi E, Corrigall V, Becker S, de Winter P, Shah A, Zamboulis C, Ritter J, Ferro A, Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J 2009 30 3048 3054. doi: 10.1093/eurheartj/ehp330.
24. McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ, Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004 125 777 787. doi: 10.1111/j.1365-2141.2004.04983.x.
25. Gkaliagkousi E, Passacquale G, Douma S, Zamboulis C, Ferro A, Platelet activation in essential hypertension: implications for antiplatelet treatment. Am J Hypertens 2010 23 229 236. doi: 10.1038/ajh.2009.247.
26. van Gils JM, Zwaginga JJ, Hordijk PL, Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009 85 195 204. doi: 10.1189/jlb.0708400.
27. Booth LC, Nishi EE, Yao ST, Ramchandra R, Lambert GW, Schlaich MP, May CN, Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension 2015 65 393 400. doi: 10.1161/HYPERTENSIONAHA.114.04176.
28. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M, Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 2010 376 1903 1909
29. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, SYMPLICITY HTN-3 Investigators A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014 370 1393 1401. doi: 10.1056/NEJMoa1402670.
30. Kandzari DE, Bhatt DL, Brar S, Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 2015 36 219 227. doi: 10.1093/eurheartj/ehu441.
31. Smithwick RH, Thompson JE, Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 1953 152 1501 1504
32. Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP, Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens 2013 31 1893 1900. doi: 10.1097/HJH.0b013e3283622e58.
33. Mahfoud F, Urban D, Teller D, Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J 2014 35 2224 231b. doi: 10.1093/eurheartj/ehu093.
34. Mancia G, Fagard R, Narkiewicz K, 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013 34 2159 2219. doi: 10.1093/eurheartj/eht151.
35. Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM, Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol 2015 31 631 641. doi: 10.1016/j.cjca.2015.02.008.
36. Mirhafez SR, Mohebati M, Feiz Disfani M, Saberi Karimian M, Ebrahimi M, Avan A, Eslami S, Pasdar A, Rooki H, Esmaeili H, Ferns GA, Ghayour-Mobarhan M, An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. J Am Soc Hypertens 2014 8 614 623. doi: 10.1016/j.jash.2014.05.007.
37. Watanabe T, Yasunari K, Nakamura M, Maeda K, Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients. J Hum Hypertens 2006 20 336 340. doi: 10.1038/sj.jhh.1001990.
38. Wenzel P, Rossmann H, Müller C, Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. Eur Heart J 2015 36 3437 3446. doi: 10.1093/eurheartj/ehv544.